New York, New York, United States The company was established in North America in United States. The leading representative office of defined Corporate Investor is situated in the New York.
Among the various public portfolio startups of the fund, we may underline Echo Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2011.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Platinum Partners, Medical Technologies Innovation Asia.
Funds with similar focus
| Fund Name | Location |
| 819 Capital | California, San Francisco, United States |
| 8capita Partners | Central, Central Region, Singapore |
| Acorn | Kansas, United States, Wa Keeney |
| African Innovation Foundation | Switzerland, Zürich, Zurich |
| AltEnergy | Alden, Iowa, United States |
| Dazi Dingcheng Ziben | - |
| Fenbushi Capital | China, Shanghai, Shanghai |
| Insight Capital | Beijing, Beijing, China |
| Iwagin Jigyo Souzou Capital | Iwate Prefecture, Japan, Morioka |
| Kelly Services | Michigan, Troy, United States |
| Life.SREDA | Central, Central Region, Singapore |
| Maverick Alternative | - |
| Movac | New Zealand, Wellington, Wellington |
| Nobori | - |
| PPL | Allentown, Pennsylvania, United States |
| Radar Endeavour Group | - |
| Taixiang Investment Management | China, Ningbo, Zhejiang |
| Tapas Capital | Bellevue, United States, Washington |
| XN | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 